Chemiluminescence imaging offers a low background and high sensitivty approach to imaging analytes in living cells and animals. Intensity-based measurements have been developed, but require careful consideration of kinetics, probe localization, and fluctuations in quantum yield, all of which complicate quantification. Here, we report a ratiometric strategy for quantitative chemiluminescence imaging of pH. The strategy relies on an energy transfer cascade of chemiluminescence emission from a spiroadamantane 1,2-dioxetane to a ratiometric pH indicator via fluorescent dyes in Enhancer solutions. Monitoring the pH-dependent changes in chemiluminescence emission at multiple wavelengths enables ratiometric imaging and quantification of pH independent from variations due to kinetics and probe concentration.
Introduction
Chemiluminescence light emission results from the relaxation of excited states formed in the course of a chemical reaction.
1
Amongst myriad natural and synthetic chemiluminescent systems that have been investigated, [2] [3] [4] [5] [6] [7] [8] triggered chemiluminescence emission from spiroadamantane 1,2-dioxetanes has emerged as particularly versatile. [9] [10] [11] A wide variety of derivatives has been synthesized and applied for in vitro measurements, 12-14 cellular experiments, [15] [16] [17] [18] and whole animal imaging. [19] [20] [21] [22] [23] Despite exciting progress, most of these systems depend on a turn-on triggered response, which is vulnerable to false negatives and positives from variable intensities due to reaction kinetics and probe localization. These issues are also endemic to intensity-based fluorescence techniques, but ratiometric imaging methods that display a wavelength-dependent change in signal form an effective strategy to address these problems. Measuring the ratio of intensities at two different wavelengths in such a system provides an internal control that is less sensitive to experimental variables like probe concentration, and can enable more precise quantification of analytes. Ratiometric fluorescence imaging probes are available for quantitative imaging of a range of cations like Ca 2+ , Zn 2+ , and Mg
2+
.
24-27
Fluorescence imaging of pH has been achieved with the ratiometric SNARF dyes and other pH sensitive indicators.
28-33
Ratiometric imaging of reactive analytes is also common, but Scheme 1. Energy transfer chemiluminescence for ratiometric pH imaging.
Scheme 2. Synthesis and isolation of phenol 1.
effective quantification requires the development of fast and reversible reactions.
34,35
By contrast, ratiometric chemiluminescent systems are rarer despite the significant improvements in signal-to-noise and reduced autofluorescence that chemiluminescence imaging offers. Bioluminescent measurement of pH is possible by taking advantage of the pH-dependent emission of luciferin. 36 While useful, this technique depends on using genetically modified organisms and the enzyme-catalyzed oxidation of luciferin depends on ATP and O 2 .
In order to capitalize on key advantages of chemiluminescence imaging including low background, Please do not adjust margins
Please do not adjust margins reduced autofluorescence, and higher sensitivity, 37,38 we report a ratiometric chemiluminescent strategy for quantitative imaging of pH. Chemiluminescence energy transfer has been previously used to red-shift emission wavelengths. 39, 40 Our approach uses an energy transfer cascade of the chemiluminescence emission from the phenolate derived from 1 to a dye in Sapphire II Enhancer or Emerald II Enhancer solutions and ending with the excitation of carboxy-SNARF-1 28 (Scheme 1), which has peak emissions at two wavelengths, 650 nm and 585 nm. The relative intensity at these two wavelengths is determined by the pH-dependent ratio of the protonated and deprotonated dye.
Results and Discussion
In order to maximize chemiluminescence emission from a spiroadamantane 1,2-dioxetane, we devised a procedure to synthesize and isolate the free phenol 1 (Scheme 2). Phenol 1 will equilibrate with the phenolate form, which spontaneously decomposes in a chemically initiated electron exchange lumninscence (CIEEL) mechanism to access the excited state and emit light. We hypothesized that protecting the phenol with a methoxymethyl ether (MOM) protecting group would enable acid-mediated deprotection after the [2+2] cycloaddition, thereby avoiding exposure of the phenol to basic conditions that are known to decompose this class of 1,2-dioxetanes. Starting from the known enol ether 2, 20 treatment
with MOMCl provided the protected enol ether 3, which was then treated with singlet oxygen generated using Rose bengal to mediate the conversion of triplet oxygen to singlet oxygen and yield 4. The MOM-protected dioxetane was then deprotected with para-toluenesulphonic acid (p-TSA) in methanol to provide the free phenol 1, which was purified by silica column chromatography. Carboxy-SNARF-1 was prepared by adapting a literature procedure.
41
With 1 and carboxy-SNARF-1 in hand, we proceeded to characterize the chemiluminescence emission of this combined system with an aim to determining the possibility of energy transfer to the ratiometric carboxy-SNARF-1. We prepared aqueous solutions of 1 and carboxy-SNARF-1 buffered to pH values between 6 and 10. In order to increase the magnitude of chemiluminescence emission, we added either Emerald II Enhancer or Sapphire II Enhancer. These proprietary solutions consist of a tetra-alkyl ammonium polymer that co-encapsulates the dioxetane and a fluorescent dye to enhance chemiluminescence emission and red-shift the emission wavelength via energy transfer. Measurements with a pH meter confirmed that there was no significant change in the pH in buffered solutions containing 6% Enhancer by volume. Solutions of 1, carboxy-SNARF-1, and Sapphire II Enhancer displayed two peaks in the chemiluminescence emission spectra at 467 nm and 650 nm ( Figure 1A ), which can be assigned to the phenolate derived from chemiluminescent decomposition of 1 (slightly red-shifted in the Sapphire II Enhancer solution) and carboxy-SNARF-1, respectively. As the pH of the solution increases, the intensity of each peak increases due to a larger equilibrium concentration of the phenolate. This is in contradistinction to fluorescence imaging using carboxy-SNARF-1, which is characterized by an isoemissive point. 42 Careful inspection of Figure 1A , however, reveals that the carboxy-SNARF-1 peak increases more rapidly with increasing pH due to increased concentration of the deprotonated form, providing the wavelength-dependent emission that is needed for ratiometric measurement. Indeed, by plotting the ratio of the chemiluminescence emission intensities of the protonated and deprotonated forms of carboxy-SNARF-1 (585 nm and 650 nm, respectively), a Please do not adjust margins ratiometric pH-dependent plot can be constructed ( Figure 1B ). This ratiometric response shows a 5.6-fold increase from pH 5.99 to pH 10.02. A similar experiment was performed using Emerald II Enhancer that displayed three peaks in the chemiluminescence emission spectra at 460 nm, 535 nm, and 650 nm ( Figure 1C ), which can be assigned to the phenolate derived from chemiluminescent decomposition of 1, Emerald II Enhancer, and carboxy-SNARF-1, respectively. Plotting the ratio of chemiluminscence emission at 650 nm and 585 nm shows a 5.7-fold increase from pH 5.99 to pH 10.02 ( Figure  1D ). We next confirmed the consistency of the ratiometric signal upon changing other variables. In previous work, we have observed a kinetic decay of the chemiluminescent signal in vivo, 21 a factor that complicates precise quantification. In this current system for chemiluminescent pH measurement, a decay of the chemiluminescence emission intensity over time is also observed in vitro using solutions of 1 and carboxy-SNARF-1 in aqueous solutions buffered to pH 7.42 containing 6% Sapphire II Enhancer (Figure 2A ). While the overall intensity decreases, analysis of the ratio of chemiluminescence emission at 650 nm and 585 nm reveals a steady signal over 30 minutes at pH 5.99, 7.42, and 8.01 ( Figure 2B ). Similar results are observed in analogous experiments using Emerald II Enhancer ( Figure 2C,D) . We also evaluated the consistency of the ratiometric signal with respect to variable probe concentrations. It is often difficult to independently determine probe localization in imaging experiments and increased localization will lead to increased signal, potentially giving false positive results. We evaluated this in vitro by increasing the concentration of 1 when mixed with solutions of carboxy-SNARF-1 and Sapphire II Enhancer ( Figure 3A ). Increased chemiluminescence emission intensity is observed with increased concentration of the dioxetane 1. The intensity of each peak, however, is increased proportionally such that if the ratio of chemiluminescence emission at 650 nm and 585 nm is plotted versus the concentration of 1, a consistent signal is observed between 20 µM and 100 µM, with a slight upward trend at 200 µM ( Figure 3B ). Similar results are observed when using the Emerald II Enhancer (Figure 3C,D) , but with less noise due to increased chemiluminescence emission at 585 nm. Next, the consistency of this ratiometric pH measurement in different environmental conditions, including complicated biological media was interrogated by comparing the ratio of chemiluminescence emission at 650 nm and 585 nm with different volumes of the Enhancer solutions and in the presence and absence of fetal bovine serum (Figure 4) . The ratio of the chemiluminescence emission at 650 nm and 585 nm (CL 650 /CL 585 ) of solutions of 60 µM 1, 80 µM carboxy-SNARF-1, and 6-14% Sapphire II Enhancer ( Figure 4A Figure 4B ) was measured. A slight reduction can be seen when increasing the concentration of the Emerald II Enhancer solution ( Figure 4B ). This decrease in the ratiometric chemiluminescent signal is smaller when using the Sapphire II Enhancer solution ( Figure 4A ). The attenuation of the ratiometric signal (CL 650 /CL 585 ) is due to an increase in the emission at 585 nm from the shoulder of the Enhancer solution emissions. This shoulder is more significant for the Emerald II Enhancer solution because the Emerald II Enhancer has a peak emission at 535 nm, which is closer to monitored 585 nm wavelength. The ratio of chemiluminescence emission at 650 nm and 585 nm (CL 650 /CL 585 ) was also measured in the presence of 10% fetal bovine serum ( Figure 4C Please do not adjust margins
Please do not adjust margins chemiluminescent measurement of pH in complex biological fluids. Finally, we established the suitability of this system for ratiometric chemiluminescence imaging of pH using an IVIS Spectrum. Images were rapidly acquired using either a 580 nm filter or a 640 nm filter. Carboxy-SNARF-1, 1, and either Sapphire II Enhancer ( Figure 5 ) or Emerald II Enhancer ( Figure  6 ) in aqueous solutions buffered at pH 6, 6.4, 6.8, 7.2, 7.4, 7.6, 7.8, or 8.0. Six replicates of each pH were imaged in a single plate. Short acquisition times of 2 seconds were used to minimize the time between image capture. Generally, light emission increases with increasing pH when using both the 580 nm filter ( Figures 5A, 6A ) and the 640 nm filter (Figures 5B, 6B) . Plotting the ratio of intensities of the two images for a given well results in a pH-dependent curve that shows an increase in the ratiometric signal (CL 640 /CL 580 ) from 3 to 12 when using the Sapphire II Enhancer ( Figure 7A ) and from 0.7 to 2.1 when using the Emerald II Enhancer ( Figure 7B ). These data demonstrate that the pH can be quantified at defined spatial locations using this chemiluminescent system and the described ratiometric imaging protocol.
Conclusions
Herein, we have realized quantitative ratiometric chemiluminescence imaging of pH via the transfer of energy from a chemiluminescent excited state of a phenolate derived Please do not adjust margins from the decomposition of 1 to the ratiometric pH sensitive dye carboxy-SNARF-1. The synthesis and isolation of 1 was of key importance in providing a bright chemiluminescent system to ensure excitation of carboxy-SNARF-1. The system provides a reliable ratiometric response to variable pH and is independent of confounding variables such as time and the concentration of the dioxetane. The system also provides an accurate measurement of pH in the presence of fetal bovine serum, demonstrating operational compatibility with complex biological fluids. Protocols have been established for the quantification of pH using chemiluminescence imaging on an IVIS Spectrum. Due to increased luminescence emission in the range between 585 nm and 650 nm, the system containing the Emerald II Enhancer provides greater signal-to-noise for pH measurement. On the other hand, the system containing the Sapphire II Enhancer provides a higher magnitude change in the ratiometric signal. Some fluctuations are seen when the volumes of the Enhancer solutions are altered, a problem that is more severe in the case of the Emerald II Enhancer. The formulation of systems with stable polymeric encapsulation or covalent linkage of components to ensure consistent stoichiometry could provide solutions to this issue. Nevertheless, quantitative imaging of pH using this ratiometric chemiluminescent system has been achieved. We ultimately anticipate that similar strategies will be compatible with the current library of known ratiometric fluorescent probes to provide a powerful new toolkit for ratiometric chemiluminescence imaging.
Experimental section

General materials and methods
All reactions were performed in dried glassware under an atmosphere of dry N 2 . Silica gel P60 (SiliCycle) was used for column chromatography and Analytical Chromatography TLC Silica gel 60 F 254 (Merck Millipore, Darmstadt, Germany) was used for analytical thin layer chromatography. Plates were visualized by fluorescence quenching under UV light or by staining with iodine. Other reagents were purchased from Sigma-Aldrich (St. Louis, MO), Alfa Aesar (Ward Hill, MA), EMD Millipore (Billerica, MA), and Oakwood Chemical (West Columbia, SC) and used without further purification. Carboxy-SNARF-1 was synthesized according to a literature procedure as a mixture isomers. 41 (1r,3r,5R,7S)-2-((4-chloro-3-methoxymethylphenyl) (methoxy)methylene)adamantine (3). DIPEA (1.00 mL, 5.7 mmol, 1.8 equiv) was added to a solution of compound 2 (954 mg, 3.1 mmol, 1.0 equiv) in 10 mL DCM at room temperature under N 2 . Then, chloromethoxymethane (0.47 mL, 6.2 mmol, 2.0 equiv) was added dropwise to the solution at 0 °C. After the addition of chloromethoxymethane, the reaction was raised to room temperature and stirred for 2.5 hours. Then, the reaction was quenched with 30 mL saturated aq NH 4 (1) . The dioxetane 4 (651.3 mg, 1.7 mmol, 1.0 equiv) was dissolved in 10 mL MeOH at room temperature. para-Toluenesulphonic acid (37.3 mg, 0.2 mmol, 0.1 equiv) was dissolved in 10 mL MeOH at room temperature. Then, the para-toluenesulphonic acid solution was added to the solution of 4 drop by drop. After addition of para-toluenesulphonic acid, the mixture was raised to 65 °C and stirred for 6.5 hours. Then, the mixture was quenched with 50 mL brine and extracted with 3 x 50 mL EtOAc and evaporated under reduced pressure. Purification by silica column chromatography (1:20 EtOAc/Hexane) yielded 1 as a white solid (303 mg, 53% 
Chemiluminescent measurement of pH
Chemiluminescent responses were acquired with a Hitachi F-7000 Fluorescence Spectrophotometer (Hitachi, Tokyo, Japan) using the luminescence detection mode. The spectrophotometer scan mode was set as wavelength scan with the range of emission wavelength from 400 nm to 900 nm and scan speed was set to 1200 nm/min. Response time was set to 2.0 s. Solutions were prepared using 463 µL of buffers (pH 6-10), 30 µL of Emerald II Enhancer or Sapphire II Enhancer, 4 µL of a 10 mM stock solution of carboxy-SNARF-1 in DMSO (80 µM final concentration) and 3 µL of a 10 mM stock solution of 1 in DMSO (60 µM final concentration) in a quartz cuvette (Starna, Atascadero, CA). The cuvette was shaken gently to assure mixing. Then the cuvette was placed in the spectrophotometer and a wavelength scan was acquired. The procedure was repeated at different time points, concentrations of the dioxetane 1, volumes of the Enhancer solutions, and in the presence of 10% fetal bovine serum as indicated in figure captions.
Ratiometric imaging
Chemiluminescent responses were acquired with an IVIS Spectrum (Caliper, Waltham, MA) using the "Luminescent" and "Photograph" mode. The exposure time was set as 2 seconds, and the binning was set to small. The F/stop was set to 4, and the FOV was set to C, which means the field of view was set to 13 cm. With these settings, images could be acquired with 267 µM spatial resolution. The height of each photograph was 1.5 cm. The excitation was blocked and a sequence was set for the emission mode. The sequence was set as 580 nm, 640 nm, 580 nm, 640 nm, 580 nm and 640 nm. 231.5 µL aliquots of PBS buffers with pH from 5.99-8.01 were added to the wells on the 96-well plate from A1 to A8. Then 2 µL of a 5 mM stock solution of carboxy-SNARF-1 (80 µM final concentration) in DMSO was added to each well followed by the addition of 15 µL Emerald II Enhancer or Sapphire II Enhancer. Then, 1.5 µL of a 5 mM stock solution of 1 in DMSO was added to each well after the adding of the buffer, enhancer and carboxy-SNARF-1. This was repeated in groups A1 to A8 for 6 times on each plate. The sequence described above was then acquired and the images were analyzed using the Living Image software.
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